MetLife Investment Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Sell |
86,954
-719
| -0.8% | -$19.8K | 0.01% | 922 |
|
|
2025
Q1 | $2.49M | Sell |
87,673
-1,684
| -2% | -$47.7K | 0.01% | 939 |
|
|
2024
Q4 | $3.72M | Buy |
89,357
+1,667
| +2% | +$69.3K | 0.02% | 728 |
|
|
2024
Q3 | $5.86M | Sell |
87,690
-1,056
| -1% | -$70.6K | 0.03% | 445 |
|
|
2024
Q2 | $10.5M | Buy |
88,746
+11,066
| +14% | +$1.31M | 0.06% | 230 |
|
|
2024
Q1 | $8.28M | Sell |
77,680
-2,857
| -4% | -$304K | 0.06% | 283 |
|
|
2023
Q4 | $8.01M | Sell |
80,537
-1,387
| -2% | -$138K | 0.06% | 277 |
|
|
2023
Q3 | $8.46M | Sell |
81,924
-1,452
| -2% | -$150K | 0.07% | 244 |
|
|
2023
Q2 | $10.1M | Sell |
83,376
-2,714
| -3% | -$330K | 0.07% | 221 |
|
|
2023
Q1 | $13.2M | Sell |
86,090
-1,023
| -1% | -$157K | 0.1% | 160 |
|
|
2022
Q4 | $15.6M | Sell |
87,113
-3,063
| -3% | -$550K | 0.12% | 135 |
|
|
2022
Q3 | $10.7M | Sell |
90,176
-3,843
| -4% | -$454K | 0.09% | 180 |
|
|
2022
Q2 | $13.4M | Sell |
94,019
-16,820
| -15% | -$2.4M | 0.1% | 152 |
|
|
2022
Q1 | $19.1M | Buy |
110,839
+32,903
| +42% | +$5.67M | 0.12% | 130 |
|
|
2021
Q4 | $19.8M | Sell |
77,936
-1,380
| -2% | -$350K | 0.16% | 103 |
|
|
2021
Q3 | $30.5M | Buy |
+79,316
| New | +$30.5M | 0.27% | 64 |
|
|
2019
Q2 | – | Sell |
-36
| Closed | -$733 | – | 2536 |
|
|
2019
Q1 | $733 | Buy |
+36
| New | +$733 | ﹤0.01% | 2561 |
|